Retrospective audit of a convenience cohort of individuals on HIV pre-exposure prophylaxis in Alberta, Canada

被引:3
作者
Candler, Ethan [1 ]
Khan, Muhammad Naeem [2 ]
Gratrix, Jennifer [1 ]
Plitt, Sabrina [3 ]
Stadnyk, Maria [1 ]
Smyczek, Petra [1 ]
Anderson, Natalie [4 ]
Carter, Julia [4 ]
Sayers, Steven [5 ]
Smith, Donna [6 ]
Ugarte-Torres, Alejandra [7 ]
Shukalek, Caley [8 ]
Singh, Ameeta E. [9 ]
机构
[1] Alberta Hlth Serv, STI Serv, Edmonton, AB, Canada
[2] Alberta Hlth Serv, Hlth Protect Communicable Dis Control Populat Publ, Edmonton, AB, Canada
[3] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada
[4] Sexual & Reprod Hlth Clin, Calgary, AB, Canada
[5] DxMed Clin, Edmonton, AB, Canada
[6] Red Deer Sexual Hlth Clin, Red Deer, AB, Canada
[7] Univ Calgary, Dept Med, Div Infect Dis, Calgary, AB, Canada
[8] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[9] Univ Alberta, Edmonton, AB, Canada
来源
JOURNAL OF THE ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA (JAMMI) | 2022年 / 7卷 / 04期
关键词
evaluation; HIV; PrEP; prevention; DOUBLE-BLIND; TENOFOVIR; INFECTION; MEN; APPOINTMENTS; REMINDERS; USERS;
D O I
10.3138/jammi-2022-0016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BACKGROUND: We undertook an audit of a province-wide HIV pre-exposure prophylaxis (PrEP) program in Alberta (Canada). METHODS: A retrospective record review of individuals accessing PrEP in Alberta included demographics, PrEP indication(s), and reported non-prescription drug and alcohol use from March 2016 to June 2019. Hepatitis A, B, C, HIV and syphilis serology, serum creatinine, and nucleic acid amplification tests testing for chlamydia and gonorrhea were collected. Descriptive statistics, incidence, and prevalence were calculated. RESULTS: A total of 511 participants were seen at STI, sexual, and reproductive health clinics and private family practitioner (FP) offices; 98.4% (503) were men, median age was 34 years (IQR 28-43 years), and 89.8% (459) were gay or bisexual men who have sex with men. Non-prescription drug use was reported by 39.3% (201) and alcohol use by 55.4% (283). 94.3% (482) reported condomless anal sex in the past 6 months. Testing rates were high (>95%) for all tests except for chlamydia and gonorrhea at the first follow-up visit 89.6%; (3-4 months). There was one HIV seroconversion. The incidence of new bacterial STIs was high: chlamydia 17 cases per 100 person-years (95% CI 13.5% to 21.4%), gonorrhea 11.14 cases per 100 person-years (95% CI 8.3% to 15.0%), and syphilis 1.94 cases per 100 person-years (95% CI 0.73% to 5.12%). CONCLUSIONS: Following implementation of a provincial program for PrEP in Alberta, PrEP initiation and continuation was feasible in a range of settings and by both specialists and FPs.
引用
收藏
页码:350 / 363
页数:14
相关论文
共 48 条
[1]  
Alberta Health, Syphilis
[2]  
Alberta Health Services, Application for designated HIV PrEP prescriber status for restricted benefit claim coverage under Alberta HIV PrEP program Internet
[3]  
Alberta Health Services, 2018, Alberta HIV pre-exposure prophylaxis (PrEP) guidelines Internet
[4]  
Alberta Health Services, 2019, HIV PrEP: Information for health professionals Internet
[5]  
Alberta Health Services, 2021, Alberta HIV pre-exposure prophylaxis (PrEP) guidelines Internet
[6]   Primary HIV-1 infection in users of pre-exposure prophylaxis [J].
Ambrosioni, Juan ;
Petit, Elisa ;
Liegeon, Geoffroy ;
Laguno, Montserrat ;
Miro, Jose M. .
LANCET HIV, 2021, 8 (03) :e166-e174
[7]   A Qualitative Study of Provider Thoughts on Implementing Pre-Exposure Prophylaxis (PrEP) in Clinical Settings to Prevent HIV Infection [J].
Arnold, Emily A. ;
Hazelton, Patrick ;
Lane, Tim ;
Christopoulos, Katerina A. ;
Galindo, Gabriel R. ;
Steward, Wayne T. ;
Morin, Stephen F. .
PLOS ONE, 2012, 7 (07)
[8]   Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial [J].
Baeten, Jared M. ;
Donnell, Deborah ;
Mugo, Nelly R. ;
Ndase, Patrick ;
Thomas, Katherine K. ;
Campbell, James D. ;
Wangisi, Jonathan ;
Tappero, Jordan W. ;
Bukusi, Elizabeth A. ;
Cohen, Craig R. ;
Katabira, Elly ;
Ronald, Allan ;
Tumwesigye, Elioda ;
Were, Edwin ;
Fife, Kenneth H. ;
Kiarie, James ;
Farquhar, Carey ;
John-Stewart, Grace ;
Kidoguchi, Lara ;
Coombs, Robert W. ;
Hendrix, Craig ;
Marzinke, Mark A. ;
Frenkel, Lisa ;
Haberer, Jessica E. ;
Bangsberg, David ;
Celum, Connie .
LANCET INFECTIOUS DISEASES, 2014, 14 (11) :1055-1064
[9]  
Bourassa Carrie, 2018, Healthc Pap, V17, P6, DOI 10.12927/hcpap.2018.25507
[10]   Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada [J].
Charest, Maxime ;
Sharma, Malika ;
Chris, Allison ;
Schnubb, Alexandre ;
Knox, David C. ;
Wilton, James ;
Shahin, Rita ;
Chan, Arlene ;
Mishra, Sharmistha ;
Grace, Daniel ;
Bayoumi, Ahmed M. ;
Maxwell, John ;
Bogoch, Isaac I. ;
Tan, Darrell H. S. .
PLOS ONE, 2021, 16 (03)